Cargando…

Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis

Ginseng, the root and rhizome of Panax ginseng C. A. Mey., is a famous herbal medicine, and its major ginsenosides exert beneficial effects on nonalcoholic fatty liver disease (NAFLD). Due to the multicomponent and multitarget features of ginsenosides, their detailed mechanisms remain unclear. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Wenyi, Zhou, Kun, Jian, Ping, Chang, Zihao, Zhang, Qiunan, Liu, Yuqi, Xiao, Shuiming, Zhang, Lanzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928318/
https://www.ncbi.nlm.nih.gov/pubmed/33679403
http://dx.doi.org/10.3389/fphar.2021.622841
_version_ 1783659829540159488
author Liang, Wenyi
Zhou, Kun
Jian, Ping
Chang, Zihao
Zhang, Qiunan
Liu, Yuqi
Xiao, Shuiming
Zhang, Lanzhen
author_facet Liang, Wenyi
Zhou, Kun
Jian, Ping
Chang, Zihao
Zhang, Qiunan
Liu, Yuqi
Xiao, Shuiming
Zhang, Lanzhen
author_sort Liang, Wenyi
collection PubMed
description Ginseng, the root and rhizome of Panax ginseng C. A. Mey., is a famous herbal medicine, and its major ginsenosides exert beneficial effects on nonalcoholic fatty liver disease (NAFLD). Due to the multicomponent and multitarget features of ginsenosides, their detailed mechanisms remain unclear. This study aimed to explore the role of ginsenosides on NAFLD and the potential mechanisms mediated by the gut microbiota and related molecular processes. C57BL/6J mice were fed a high-fat diet (HFD) supplemented or not supplemented with ginsenoside extract (GE) for 12 weeks. A strategy that integrates bacterial gene sequencing, serum pharmacochemistry and network pharmacology was applied. The results showed that GE significantly alleviated HFD-induced NAFLD symptoms in a dose-dependent manner. Furthermore, GE treatment modulated the HFD-induced imbalance in the gut microbiota and alleviated dysbiosis-mediated gut leakage and metabolic endotoxemia. Additionally, 20 components were identified in the mouse plasma after the oral administration of GE, and they interacted with 82 NAFLD-related targets. A network analysis revealed that anti-inflammatory effects and regulation of the metabolic balance might be responsible for the effects of GE on NAFLD. A validation experiment was then conducted, and the results suggested that GE suppressed NF-κB/IκB signaling activation and decreased the release and mRNA levels of proinflammatory factors (TNF-α, IL-1β and IL-6). Additionally, GE promoted hepatic lipolytic genes (CPT-1a), inhibited lipogenic genes (SREBP-1c, FAS, ACC-1) and improved leptin resistance. These findings imply that the benefits of GE are involved in modulating the gut microbiota, enhancing the gut barrier function, restoring the energy balance, and alleviating metabolic inflammation. Moreover, GE might serve as a potential agent for the prevention of NAFLD through the integration of prebiotic, anti-inflammatory and energy-regulatory effects.
format Online
Article
Text
id pubmed-7928318
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79283182021-03-04 Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis Liang, Wenyi Zhou, Kun Jian, Ping Chang, Zihao Zhang, Qiunan Liu, Yuqi Xiao, Shuiming Zhang, Lanzhen Front Pharmacol Pharmacology Ginseng, the root and rhizome of Panax ginseng C. A. Mey., is a famous herbal medicine, and its major ginsenosides exert beneficial effects on nonalcoholic fatty liver disease (NAFLD). Due to the multicomponent and multitarget features of ginsenosides, their detailed mechanisms remain unclear. This study aimed to explore the role of ginsenosides on NAFLD and the potential mechanisms mediated by the gut microbiota and related molecular processes. C57BL/6J mice were fed a high-fat diet (HFD) supplemented or not supplemented with ginsenoside extract (GE) for 12 weeks. A strategy that integrates bacterial gene sequencing, serum pharmacochemistry and network pharmacology was applied. The results showed that GE significantly alleviated HFD-induced NAFLD symptoms in a dose-dependent manner. Furthermore, GE treatment modulated the HFD-induced imbalance in the gut microbiota and alleviated dysbiosis-mediated gut leakage and metabolic endotoxemia. Additionally, 20 components were identified in the mouse plasma after the oral administration of GE, and they interacted with 82 NAFLD-related targets. A network analysis revealed that anti-inflammatory effects and regulation of the metabolic balance might be responsible for the effects of GE on NAFLD. A validation experiment was then conducted, and the results suggested that GE suppressed NF-κB/IκB signaling activation and decreased the release and mRNA levels of proinflammatory factors (TNF-α, IL-1β and IL-6). Additionally, GE promoted hepatic lipolytic genes (CPT-1a), inhibited lipogenic genes (SREBP-1c, FAS, ACC-1) and improved leptin resistance. These findings imply that the benefits of GE are involved in modulating the gut microbiota, enhancing the gut barrier function, restoring the energy balance, and alleviating metabolic inflammation. Moreover, GE might serve as a potential agent for the prevention of NAFLD through the integration of prebiotic, anti-inflammatory and energy-regulatory effects. Frontiers Media S.A. 2021-02-12 /pmc/articles/PMC7928318/ /pubmed/33679403 http://dx.doi.org/10.3389/fphar.2021.622841 Text en Copyright © 2021 Liang, Zhou, Jian, Chang, Zhang, Liu, Xiao and Zhang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liang, Wenyi
Zhou, Kun
Jian, Ping
Chang, Zihao
Zhang, Qiunan
Liu, Yuqi
Xiao, Shuiming
Zhang, Lanzhen
Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis
title Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis
title_full Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis
title_fullStr Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis
title_full_unstemmed Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis
title_short Ginsenosides Improve Nonalcoholic Fatty Liver Disease via Integrated Regulation of Gut Microbiota, Inflammation and Energy Homeostasis
title_sort ginsenosides improve nonalcoholic fatty liver disease via integrated regulation of gut microbiota, inflammation and energy homeostasis
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928318/
https://www.ncbi.nlm.nih.gov/pubmed/33679403
http://dx.doi.org/10.3389/fphar.2021.622841
work_keys_str_mv AT liangwenyi ginsenosidesimprovenonalcoholicfattyliverdiseaseviaintegratedregulationofgutmicrobiotainflammationandenergyhomeostasis
AT zhoukun ginsenosidesimprovenonalcoholicfattyliverdiseaseviaintegratedregulationofgutmicrobiotainflammationandenergyhomeostasis
AT jianping ginsenosidesimprovenonalcoholicfattyliverdiseaseviaintegratedregulationofgutmicrobiotainflammationandenergyhomeostasis
AT changzihao ginsenosidesimprovenonalcoholicfattyliverdiseaseviaintegratedregulationofgutmicrobiotainflammationandenergyhomeostasis
AT zhangqiunan ginsenosidesimprovenonalcoholicfattyliverdiseaseviaintegratedregulationofgutmicrobiotainflammationandenergyhomeostasis
AT liuyuqi ginsenosidesimprovenonalcoholicfattyliverdiseaseviaintegratedregulationofgutmicrobiotainflammationandenergyhomeostasis
AT xiaoshuiming ginsenosidesimprovenonalcoholicfattyliverdiseaseviaintegratedregulationofgutmicrobiotainflammationandenergyhomeostasis
AT zhanglanzhen ginsenosidesimprovenonalcoholicfattyliverdiseaseviaintegratedregulationofgutmicrobiotainflammationandenergyhomeostasis